피부경화증 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "피부경화증" in Korean language version.

refsWebsite

Global rank Korean rank

9nih.gov

4^th place

7web.archive.org

1^st place

7doi.org

2^nd place

3^rd place

2google.ca

838^th place

317^th place

1rarediseases.org

5,181^st place

3,032^nd place

1merckmanuals.com

3,097^th place

1,083^rd place

doi.org

dx.doi.org

Barnes J, Mayes MD (March 2012). “Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers.”. 《Current Opinion in Rheumatology》 24 (2): 165–70. doi:10.1097/BOR.0b013e32834ff2e8. PMID 22269658.
Greenblatt MB, Aliprantis AO (January 2013). “The immune pathogenesis of scleroderma: context is everything.” (PDF). 《Current Rheumatology Reports》 15 (1): 297. doi:10.1007/s11926-012-0297-8. PMC 3539168. PMID 23288576. 2017년 9월 8일에 원본 문서 (PDF)에서 보존된 문서.
Balbir-Gurman A, Braun-Moscovici Y (February 2012). “Scleroderma - New aspects in pathogenesis and treatment”. 《Best Practice & Research Clinical Rheumatology》 26 (1): 13–24. doi:10.1016/j.berh.2012.01.011. PMID 22424190.
Dospinescu P, Jones GT, Basu N (March 2013). “Environmental risk factors in systemic sclerosis.”. 《Current Opinion in Rheumatology》 25 (2): 179–83. doi:10.1097/BOR.0b013e32835cfc2d. PMID 23287382.
Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, Bravard P, Noel D, Cailleux AF, Weber J, Lagoutte P, Benichou J, Levesque H (February 2014). “Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature.”. 《Autoimmunity Reviews》 13 (2): 151–6. doi:10.1016/j.autrev.2013.10.002. PMID 24129037.
Walker KM, Pope J (August 2012). “Treatment of systemic sclerosis complications: what to use when first-line treatment fails — a consensus of systemic sclerosis experts.”. 《Seminars in Arthritis and Rheumatism》 42 (1): 42–55. doi:10.1016/j.semarthrit.2012.01.003. PMID 22464314.
Lidar M, Langevitz P (May 2012). “Pregnancy issues in scleroderma.”. 《Autoimmunity Reviews》 11 (6-7): A515–9. doi:10.1016/j.autrev.2011.11.021. PMID 22155199.

google.ca

books.google.ca

Unsal, Erbil (2006). 《Current Opinions in Pediatric Rheumatology》 (영어). Nova Publishers. 302쪽. ISBN 9781594548710. 2017년 9월 6일에 원본 문서에서 보존된 문서.
Firestein, Gary S.; Kelley, William N.; Budd, Ralph C. (2012). 《Kelley's Textbook of Rheumatology》 (영어). Elsevier Health Sciences. 1366쪽. ISBN 1437717381. 2017년 8월 4일에 원본 문서에서 보존된 문서.

merckmanuals.com

Hajj-ali, RA (June 2013). “Systemic Sclerosis”. 《Merck Manual Professional》. Merck Sharp & Dohme Corp. 6 March 2014에 원본 문서에서 보존된 문서. 5 March 2014에 확인함.

nih.gov

ncbi.nlm.nih.gov

Barnes J, Mayes MD (March 2012). “Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers.”. 《Current Opinion in Rheumatology》 24 (2): 165–70. doi:10.1097/BOR.0b013e32834ff2e8. PMID 22269658.
Greenblatt MB, Aliprantis AO (January 2013). “The immune pathogenesis of scleroderma: context is everything.” (PDF). 《Current Rheumatology Reports》 15 (1): 297. doi:10.1007/s11926-012-0297-8. PMC 3539168. PMID 23288576. 2017년 9월 8일에 원본 문서 (PDF)에서 보존된 문서.
Balbir-Gurman A, Braun-Moscovici Y (February 2012). “Scleroderma - New aspects in pathogenesis and treatment”. 《Best Practice & Research Clinical Rheumatology》 26 (1): 13–24. doi:10.1016/j.berh.2012.01.011. PMID 22424190.
Dospinescu P, Jones GT, Basu N (March 2013). “Environmental risk factors in systemic sclerosis.”. 《Current Opinion in Rheumatology》 25 (2): 179–83. doi:10.1097/BOR.0b013e32835cfc2d. PMID 23287382.
Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, Bravard P, Noel D, Cailleux AF, Weber J, Lagoutte P, Benichou J, Levesque H (February 2014). “Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature.”. 《Autoimmunity Reviews》 13 (2): 151–6. doi:10.1016/j.autrev.2013.10.002. PMID 24129037.
Walker KM, Pope J (August 2012). “Treatment of systemic sclerosis complications: what to use when first-line treatment fails — a consensus of systemic sclerosis experts.”. 《Seminars in Arthritis and Rheumatism》 42 (1): 42–55. doi:10.1016/j.semarthrit.2012.01.003. PMID 22464314.
Lidar M, Langevitz P (May 2012). “Pregnancy issues in scleroderma.”. 《Autoimmunity Reviews》 11 (6-7): A515–9. doi:10.1016/j.autrev.2011.11.021. PMID 22155199.

rarediseases.info.nih.gov

“Scleroderma”. 《GARD》 (영어). 2017. 25 January 2017에 원본 문서에서 보존된 문서. 14 July 2017에 확인함.

niams.nih.gov

“Handout on Health: Scleroderma”. 《NIAMS》. August 2016. 2017년 7월 4일에 원본 문서에서 보존된 문서. 15 July 2017에 확인함.

rarediseases.org

“Scleroderma”. 《NORD (National Organization for Rare Disorders)》. 2007. 8 September 2016에 원본 문서에서 보존된 문서. 14 July 2017에 확인함.

web.archive.org

“Scleroderma”. 《NORD (National Organization for Rare Disorders)》. 2007. 8 September 2016에 원본 문서에서 보존된 문서. 14 July 2017에 확인함.
“Scleroderma”. 《GARD》 (영어). 2017. 25 January 2017에 원본 문서에서 보존된 문서. 14 July 2017에 확인함.
Greenblatt MB, Aliprantis AO (January 2013). “The immune pathogenesis of scleroderma: context is everything.” (PDF). 《Current Rheumatology Reports》 15 (1): 297. doi:10.1007/s11926-012-0297-8. PMC 3539168. PMID 23288576. 2017년 9월 8일에 원본 문서 (PDF)에서 보존된 문서.
“Handout on Health: Scleroderma”. 《NIAMS》. August 2016. 2017년 7월 4일에 원본 문서에서 보존된 문서. 15 July 2017에 확인함.
Unsal, Erbil (2006). 《Current Opinions in Pediatric Rheumatology》 (영어). Nova Publishers. 302쪽. ISBN 9781594548710. 2017년 9월 6일에 원본 문서에서 보존된 문서.
Firestein, Gary S.; Kelley, William N.; Budd, Ralph C. (2012). 《Kelley's Textbook of Rheumatology》 (영어). Elsevier Health Sciences. 1366쪽. ISBN 1437717381. 2017년 8월 4일에 원본 문서에서 보존된 문서.
Hajj-ali, RA (June 2013). “Systemic Sclerosis”. 《Merck Manual Professional》. Merck Sharp & Dohme Corp. 6 March 2014에 원본 문서에서 보존된 문서. 5 March 2014에 확인함.